8-K
filed March 9, 2026, 7:59 PM ET
ticker VTAK
CIK 0001716621
M&A
confidence high
sentiment neutral
materiality 0.70
Catheter Precision acquires 80% of Fly Flyte and Ponderosa Air for $11.6M; raises up to $39M in PIPE
Catheter Precision, Inc.
- Acquisition of 80.02% of Fly Flyte, Inc. and 100% of Ponderosa Air from Creatd for $11.55M in cash and Series D preferred stock.
- Private placement of Series C convertible preferred stock raises $1.85M at first close, potential additional raises up to $35.6M.
- Proceeds used for restructuring legacy catheter business, potential sale of medical devices, and reducing cash burn.
- Conversion prices start at $1.43, adjust to 80% of market with $0.35 floor, subject to stockholder approval.
- Registration rights agreement filed to register resale of conversion shares within 30–60 days of closing.
Key facts
Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.85
Catheter Precision, Inc. issued 1,853 shares of Series C-3 Convertible Preferred Stock of preferred stock to accredited investors for aggregate purchase price of $1,853,000.00.
- Security
- preferred stock
- Shares
- 1,853 shares of Series C-3 Convertible Preferred Stock
- Purchaser
- accredited investors
- Consideration
- aggregate purchase price of $1,853,000.00
Exact text from the filing
pursuant to the Financing Purchase Agreement, the Purchasers agreed to purchase (i) 1,853 shares of the Company’s newly-designated Series C-2 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, for an aggregate purchase price of $1,853,000.00 (the “Series C-2 Preferred Stock”), and (ii) 1,853 shares of the Company’s newly-designated Series C-3 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, for an aggregate purchase price of $1,853,000.00 (the “Series C-3 Preferred Stock” and, together with the Series C-1 Preferred Stock and Series C-2 Preferred Stock, the “Initial Preferred Stock”)
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.85
Catheter Precision, Inc. issued 1,853 shares of Series C-2 Convertible Preferred Stock of preferred stock to accredited investors for aggregate purchase price of $1,853,000.00.
- Security
- preferred stock
- Shares
- 1,853 shares of Series C-2 Convertible Preferred Stock
- Purchaser
- accredited investors
- Consideration
- aggregate purchase price of $1,853,000.00
Exact text from the filing
pursuant to the Financing Purchase Agreement, the Purchasers agreed to purchase (i) 1,853 shares of the Company’s newly-designated Series C-2 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, for an aggregate purchase price of $1,853,000.00 (the “Series C-2 Preferred Stock”), and (ii) 1,853 shares of the Company’s newly-designated Series C-3 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, for an aggregate purchase price of $1,853,000.00 (the “Series C-3 Preferred Stock” and, together with the Series C-1 Preferred Stock and Series C-2 Preferred Stock, the “Initial Preferred Stock”)
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Catheter Precision, Inc. issued 1,853 shares of Series C-1 Convertible Preferred Stock of preferred stock to accredited investors for aggregate purchase price of $1,853,000.
- Security
- preferred stock
- Shares
- 1,853 shares of Series C-1 Convertible Preferred Stock
- Purchaser
- accredited investors
- Consideration
- aggregate purchase price of $1,853,000
Exact text from the filing
On March 9, 2026, Catheter Precision, Inc. (the “Company”) entered into a securities purchase agreement (the “Financing Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement Financing”) of an aggregate of 1,853 shares of the Company’s Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 1,295,805 shares of common stock, par value $0.0001 per share (“Common Stock”), at an initial conversion price of $1.43 per share (the “Series C-1 Preferred Stock”) for an aggregate purchase price of $1,853,000
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Catheter Precision, Inc.: Amendment to Series C-1 Certificate of Designations to increase authorized shares from 1,783.33 to 3,636.33 (effective 2026-03-06).
- Change
- charter amendment
- Effective
- 2026-03-06
Exact text from the filing
In connection with the entrance into the Financing Purchase Agreement, the holders of the majority of the outstanding shares of Series C-1 Preferred Stock agreed to amend the Series C-1 Certificate of Designations by filing a Certificate of Amendment (“Certificate of Amendment”) to the Series C-1 Certificate of Designations with the Secretary of State of the State of Delaware (the “Secretary of State”) to increase the number of authorized shares of Series C-1 Preferred Stock from 1,783.33 to 3,636.33, in order to authorize a sufficient number of shares of Preferred Stock for the transactions contemplated by the Acquisition Purchase Agreement. On March 6, 2026, the Company filed the Certificate of Amendment with the Secretary of State, thereby amending the Certificate of Designations.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Catheter Precision, Inc. entered into Financing Purchase Agreement with certain accredited investors valued at an aggregate purchase price of $1,853,000 (effective 2026-03-09).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain accredited investors
- Value
- an aggregate purchase price of $1,853,000
- Effective
- 2026-03-09
Exact text from the filing
On March 9, 2026, Catheter Precision, Inc. (the “Company”) entered into a securities purchase agreement (the “Financing Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”)
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.